Nymox Pharmaceutical OverviewNymox Pharmaceutical Operating Income
Operating Income for NYMX.
Quarterly Operating Income
$-1099000.00
↓ 38.01% YoY
As of Jun 30, 2023
Annual Operating Income (TTM)
$-2289000.00
↓ 82.31% YoY
Trailing 12 months ending Jun 30, 2023